France 2030: 16 new programs of excellence supported to accelerate health research and innovation

2023-05-16 14:19:31

Research, whether fundamental, translational or clinical, is the first step in enabling health innovations to emerge and benefit patients and the healthcare system. Today, the President of the Republic announces 4 new bioclusters, 12 new university hospital institutes and various research infrastructures, which will receive financial support from the State to accelerate health research and innovation. They complete the 7 research programs, the first biocluster already launched, and the 7 IHU in operation. On this occasion, a new call for projects to create chairs of excellence and thus attract and retain very high-level researchers in France is also launched.

At the Institut Curie (Saint-Cloud) on May 16, the President of the Republic announced major new investments to strengthen health research in France and accelerate the transition from research to care. These investments aim to attract and retain very high-level researchers in the territory, to provide research teams with the best technologies and methodologies and to ensure a continuum from discovery to industrialization and application for the benefit of the patient.

4 new bioclusters and 12 new IHUs have thus been created throughout the territory. These centers of excellence will make it possible, by bringing together researchers, clinicians, investors and industrialists, to develop together innovative treatments and solutions that will allow tomorrow significant advances for patients in many fields: neurosciences, immunology, infectiology, gene therapies, vascular diseases, child neurodevelopmental disorders, cancers, onco-haematology, respiratory diseases, hearing disorders, sepsis, liver pathologies, etc.

In addition, investments devoted to strengthening research infrastructures in biology and health will be increased to the tune of 100 million euros. These infrastructures are essential to French research teams through the methodological and technological support they provide, for example on genomics, phenotyping, the bioproduction of innovative drugs, the study of highly pathogenic agents, etc.

Finally, a call for projects will be launched in a few days to offer teams of leading researchers from all backgrounds substantial funding over a period of 5 years to carry out their research programs in France. This AAP Chair of Excellence aims to attract researchers working abroad to France and give the best researchers the opportunity to create competitive teams in France at the highest international level.

Biomedical research is an important focus of the Health Innovation 2030 plan, the health component of France 2030, and is at the heart of the roadmap recently presented by the Prime Minister: of the €7.5 billion allocated to this plan, more than 1 billion will be devoted to research and other programs of excellence will be launched soon. To structure research and create or consolidate French leadership, seven research programs are currently at work, including two exploratory programs. They are supported by INSERM, INRIA, CEA, CNRS, CIRAD, IRD, University of Strasbourg, University of Paris Sciences and Letters, and University Côte d’Azur.

All of these programs of excellence will be monitored and supported by the Health Innovation Agency, which leads the Health Innovation 2030 plan, the health component of France 2030, within the General Secretariat for Investment, and in link with the Ministries of Higher Education and Research, Health and Prevention, and Industry. These programs are operated on behalf of the State by the National Research Agency.

---

See the press kit below

---

_{Cover of the press kit “Health Innovation 2023” (clickable image)}

Contacts presse

Ministry of Higher Education, Research and Innovation

[e-mail]

01 55 55 82 00

Ministry of Health and Prevention

[e-mail]

01 40 56 60 60

Ministry of Industry

[e-mail]

01 53 18 46 19

General Secretariat for Investment / Health Innovation Agency

[e-mail] / [e-mail]

About France 2030

The France 2030 investment plan:

• Reflects a double ambition: sustainably transform key sectors of our economy (health, energy, automotive, aeronautics or even space) through technological innovation, and position France not only as a player, but as a leader in the world of tomorrow. From basic research, to the emergence of an idea, to the production of a new product or service, France 2030 supports the entire life cycle of innovation up to its industrialization;
• Is unprecedented in its magnitude: €54 billion will be invested so that our companies, universities and research organizations fully succeed in their transitions in these strategic sectors. The challenge: to enable them to respond in a competitive way to the ecological and attractiveness challenges of the coming world, and to bring out the future leaders of our sectors of excellence. France 2030 is defined by two cross-cutting objectives consisting of devoting 50% of its expenditure to the decarbonisation of the economy, and 50% to emerging players, carriers of innovation without unfavorable expenditure on the environment (in the sense of the Do No principle). Significant Harm).
• Will be implemented collectively: designed and deployed in consultation with economic, academic, local and European players to determine its strategic orientations and key actions. Project leaders are invited to submit their file via open, demanding and selective procedures to benefit from the support of the State.
• Is driven by the General Secretariat for Investment on behalf of Prime Minister.

More information on : | @SGPI_future

1684304195
#France #programs #excellence #supported #accelerate #health #research #innovation